News

MCA is a chemical intermediate which is widely used for the production of agrochemicals, carboxymethylcellulose (CMC), surfactants and a variety of other applications. AkzoNobel said that its Taixing

Levadex is an orally inhaled migraine therapy that has completed Phase 3 efficacy development for the acute treatment of migraine. The trial was initiated in support of a

The project is expected to be managed by Fraunhofer USA Center for Molecular Biotechnology (CMB) pursuant to the long-term agreement between iBio and CMB for advancement of the

Sun Pharmaceutical said that these generic Bupropion Hydrochloride extended release tablets are equivalent to GlaxoSmithKline’s Wellbutrin SR extended release tablets and includes three strengths: 100mg, 150mg and 200mg.

Swedish Orphan Biovitrum is expected to distribute Willfact in Germany, Sweden, Norway, Iceland, Denmark, Estonia, Latvia, Lithuania, Czech Republic, Slovakia, Hungary and Bulgaria, under the agreement with LFB.

EndoChoice said that its GI diagnostics division offers the broad range of diagnostic products and services in the industry, including anatomic pathology services, immunochemical fecal occult blood tests

The new representation centre is expected to intensify Gerresheimer’s business in pharmaceutical primary packaging and drug-delivery systems. Gerresheimer said that the regional representation is expected to contribute to

Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is expressed on malignant Hodgkin lymphoma cells. The Phase III trial, also known as Aethera, is expected

Vivalis said that the milestone recognises the completion of the characterisation program of the EB66 cell line according to the current regulatory requirements. The worldwide collaboration and license